Skip to main content Back to Top
Advertisement

USP Chapter Revisions: What’s Next?

November 1, 2022

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

USP recently published final revisions to the nonsterile compounding chapter <795> and the sterile compounding chapter <797>. ASHP Senior Director of Pharmacy Practice and Quality Michael Ganio discusses the revisions, what to expect before the chapters become official, and implications for chapter <800> with compounding expert Patti Kienle.

SPEAKERS

Patricia KienlePatricia Kienle, RPh, MPA, BCSCP, FASHP is the director of accreditation and medication safety for Cardinal Health. She graduated from the Philadelphia College of Pharmacy and Science and completed a Master's in Public Administration from Marywood University in Scranton, Pennsylvania. She served on the Board of Directors of ASHP and as President of the Pennsylvania Society. She has received the Distinguished Leadership Award, the Webb Lecture Award, and Harvey A.K. Whitney Lecture Award from ASHP and the Lifetime Achievement Award from ISMP. She is a current member of the USP Compounding Expert Committee.

Michael GanioMichael Ganio is Senior Director of Pharmacy Practice and Quality at ASHP. Dr. Ganio joined the staff at ASHP in January, 2018, after nearly two decades in hospital and health-system pharmacy practice. His responsibilities at ASHP span the practice of pharmacy and include drug shortages, pharmaceutical quality, sterile and non-sterile compounding, hazardous drug safety, and other practice-related topics.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.